GSE228263 FDX1 overexpression SU-DHL-4 Elesclomol 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE228263_FDX1 overexpression_SU-DHL-4_Elesclomol_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE228263_FDX1 overexpression_SU-DHL-4_Elesclomol_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE228263_FDX1 overexpression_SU-DHL-4_Elesclomol_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE228263_FDX1 overexpression_SU-DHL-4_Elesclomol_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

lactotransferrin

Gene

C-X-C motif chemokine ligand 8

Gene

GNAS complex locus

Gene

serpin family A member 1

Gene

interferon alpha inducible protein 6

Gene

interferon induced protein 44 like

Gene

alpha-2-glycoprotein 1, zinc-binding

Gene

galectin 3 binding protein

Gene

lysozyme

Gene

toll like receptor 4

  • Gene

    lactotransferrin


  • Gene

    C-X-C motif chemokine ligand 8


  • Gene

    GNAS complex locus


  • Gene

    serpin family A member 1


  • Gene

    interferon alpha inducible protein 6


  • Gene

    interferon induced protein 44 like


  • Gene

    alpha-2-glycoprotein 1, zinc-binding


  • Gene

    galectin 3 binding protein



  • Gene

    toll like receptor 4

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.